The specific biomarkers also include more cancer-specific markers, such as HER2neu and MUC1 in breast cancer, androgen receptor (AR), early growth response gene (EGR) and PSA in prostate cancer [45,46,47]. This evidence concerns the gene AR and prostate carcinoma.